Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Hepatitis C may raise risk of certain head and neck cancers

Hepatitis C may raise risk of certain head and neck cancers

[ad_1]

Researchers have long known that hepatitis C can raise the risk of liver cancer and non-Hodgkin\’s lymphoma. But according to new research, the virus may also heighten the risk of certain head and neck cancers, including cancers of the oral cavity and larynx.
\"[Hepatitis
Patients infected with HCV may be at higher risk for developing certain head and neck cancers.

Study co-author Dr. Harrys A. Torres, of the Department of Infectious Diseases, Infection Control and Employee Health at the University of Texas MD Anderson Cancer Center, and colleagues publish their findings in the Journal of the National Cancer Institute.

Hepatitis C is the most common blood-borne infection in the US; almost 30,000 Americans have acute hepatitis C virus (HCV) infection, while around 3.5 million Americans have chronic HCV infection.

According to the Centers for Disease Control and Prevention (CDC), around 75-85% of people infected with HCV will go on to develop chronic infection, of whom around 60-70% will develop chronic liver disease.

Over a 20-30-year period, it is estimated that around 5-20% of people with chronic HCV infection will develop cirrhosis, while around 1-5% will die from cirrhosis or liver cancer. Chronic HCV infection has also been linked to increased risk of the blood cancer non-Hodgkin\’s lymphoma.

Now, for the first time, Dr. Torres and colleagues have identified a link between HCV and head and neck cancers – a finding they say could have important implications for the screening of HCV and the treatment of such cancers.

Assessing the link between HCV and head and neck cancers

To reach their findings, the team identified 34,545 patients who were tested for HCV at the MD Anderson Cancer Center between 2004-2014.

Fast facts about HCV

  • Around 70-80% of people with acute HCV do not have any symptoms
  • If symptoms do occur, they arise around 6-7 weeks after exposure to the virus
  • Symptoms include fever, fatigue, nausea, vomiting, loss of appetite, abdominal pain and dark urine.

Learn more about HCV

Of these patients, 409 had head and neck cancers, of whom 164 had oropharyngeal cancers and 245 had non-oropharyngeal cancers.

Oropharyngeal cancers are cancers that begin in the oropharynx – the middle section of the throat – including the back one third of the tongue, soft palate, the side and back walls of the throat and the tonsils.

Non-oropharyngeal cancers are cancers that begin in the mouth, including the front two thirds of the tongue, the hard palate (roof of the mouth), the floor of the mouth under the tongue, the larynx, the gums and lips.

The researchers note that it was important to account for smoking in this study, as it is a key risk factor for head and neck cancers. As such, they pinpointed 694 control patients who had been diagnosed with a smoking-related cancer, including lung, bladder and esophageal cancers.

All patients included in the study underwent testing for HCV antibodies, and – where possible – patients had viral RNA tests, which were used to confirm the presence of chronic HCV infection.

Up to five times greater risk for certain head, neck cancers with HCV

The researchers found that 20% of patients with non-oropharyngeal cancers and 14% of patients with oropharyngeal cancers tested positive for HCV antibodies, compared with only 6.5% of patients in the control group.

Assessing the risk for specific head and neck cancers, the researchers found that patients with HCV infection were at 2.4 times increased risk for oral cavity cancers, 2.04 times greater risk for oropharynx cancers and 4.96 times increased risk for larynx cancers.

\”Our findings tell us that the association between hepatitis C and oropharyngeal and non-oropharyngeal cancers is as high as its link to non-Hodgkin\’s lymphoma,\” notes Dr. Torres; previous studies have shown that patients infected with HCV may be two to three times more likely to develop non-Hodgkin\’s lymphoma.

The team notes that 145 of the patients with oropharyngeal cancers were also tested for human papillomavirus (HPV) in order to determine whether there is a link between HPV, HCV and head and neck cancers.

The researchers found that patients with oropharyngeal cancers who tested positive for HCV were also more likely to test positive for HPV – a finding that Dr. Torres says should be investigated in future studies.


Important implications for HCV screening and treatment

While the researchers\’ results may be a concern for patients with HCV, they note that in recent years, new antiviral drugs have emerged, which have been found to cure more than 90% of patients with the virus.

As such, the team says the findings highlight the importance of screening for HCV, noting that diagnosing and treating the condition with antiviral drugs could prevent head and neck cancers from developing.

The results may also have important implications for patients who have already been diagnosed with head and neck cancers.

The team explains that the National Comprehensive Cancer Network guidelines suggest that HCV should be treated first among non-Hodgkin\’s lymphoma patients with the virus, given that HCV can be cured. Could the same strategy work for HCV-infected patients with head and neck cancers?

This is the question the team wants to find the answer to. The researchers now plan to screen and treat all HCV-infected head and neck cancer patients at MD Anderson and monitor their outcomes.

\”What we are trying to make all understand is that this is an infection that has consequences – and it\’s an infection we can cure,\” says Dr. Torres.

Last month, Medical News Today reported on a review from the World Health Organization (WHO) that found HIV (human immunodeficiency virus) and HCV co-infect more than 2 million people across the globe.

[ad_2]

About author